Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) Director Blake Borgeson sold 17,770 shares of the company’s stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $11.16, for a total transaction of $198,313.20. Following the completion of the sale, the director now directly owns 7,469,615 shares of […]
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) Director Blake Borgeson sold 17,770 shares of the firm’s stock in a transaction on Tuesday, August 8th. The stock was sold at an average price of $11.16, for a total value of $198,313.20. Following the sale, the director now directly owns 7,469,615 shares in the company, valued […]
Needham & Company LLC reiterated their buy rating on shares of Recursion Pharmaceuticals (NASDAQ:RXRX – Free Report) in a research note released on Wednesday, Benzinga reports. They currently have a $17.00 price target on the stock. Other equities analysts have also recently issued reports about the company. Morgan Stanley began coverage on Recursion Pharmaceuticals in […]
Baillie Gifford & Co. Buys 314,680 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) Director Blake Borgeson sold 8,885 shares of the company’s stock in a transaction dated Tuesday, June 27th. The shares were sold at an average price of $7.39, for a total transaction of $65,660.15. Following the transaction, the director now directly owns 7,528,989 shares of the company’s stock, valued […]